This article has been updated from a previous version to include comments from Bio-Rad's earnings call.

NEW YORK (GenomeWeb) – Bio-Rad said after the close of the market Thursday that its third quarter revenues increased 5 percent year over year.

For the three months ended Sept. 30, the Hercules, California-based life science research and clinical diagnostics firm tallied sales of $535.0 million compared to $508.7 million in the year-ago period, beating analysts' average estimate of $508 million. On a currency-neutral basis, net sales grew 3 percent in the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.